Haloperidol discontinuation for people with schizophrenia
نویسندگان
چکیده
منابع مشابه
Participation of People With Schizophrenia in Everyday Life: Family’s Perspective
Objectives: People with chronic mental health condition like schizophrenia experience a lot of changes in their lives, in addition to their symptoms. The present study used a thematic analysis to explore the participation of people with schizophrenia in daily life from family’s perspective. It has uncovered some of the contributing factors in the everyday life participation of this group. Met...
متن کاملIndependent and Social Living Skills Training for People with Schizophrenia in Iran: a Randomized Controlled Trial
Objectives: Schizophrenia is responsible for a significant proportion of burden of mental diseases in Iran. Lack of a follow-up system has resulted in the repeated hospitalizations. In this study it is hypothesized that standardized living skills training delivered to participants with schizophrenia in outpatient and inpatient centers can be effective compared to a control group (with occ...
متن کاملMusic therapy for people with schizophrenia and schizophrenia-like disorders.
BACKGROUND Music therapy is a therapeutic method that uses musical interaction as a means of communication and expression. The aim of the therapy is to help people with serious mental disorders to develop relationships and to address issues they may not be able to using words alone. OBJECTIVES To review the effects of music therapy, or music therapy added to standard care, compared with 'plac...
متن کاملOpen Drug Trial with Haloperidol Decanoate Injections in Schizophrenia
The present study reports results pertaining to an "open trial" with long acting haloperidol decanoate injections in the maintenance therapy of schizophrenic patients satisfying DSM-III criteria. 33 patients suffering from schizophrenia entered the trial and were put or long acting haloperidol decanoate injections. The follow-up period was 6 months and the condition of the patients was monitore...
متن کاملTreatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone
OBJECTIVE This study compares 3 cohorts of patients with schizophrenia before, during, and after initiating treatment with fluphenazine decanoate (FD), haloperidol decanoate (HD), or long-acting injectable risperidone (LAR). METHODS Administrative data are analyzed from California Medicaid (Medi-Cal) beneficiaries with schizophrenia who initiated FD, HD, or LAR treatment. Patients were requir...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cochrane Database of Systematic Reviews
سال: 2019
ISSN: 1465-1858
DOI: 10.1002/14651858.cd011408.pub2